Table 1. Behavioral and Clinical Outcomes at Baseline and at 3-Month Follow-Up, Intervention Versus Comparison Group: East Harlem, New York City, 2015.

	Intervention group (n=199)			Comparison group (n=171)			Estimated between-group difference
Outcome	Baseline	3-month FU	p-value	Baseline	3-month FU	p-value	Difference (95% CI)	p-value
Measured clinical outcomes, M (SD)
Systolic blood pressure (SBP)	132.8 (21.3)	133.0 (22.1)	0.866	128.8 (20.8)	124.3 (19.4)	0.004	3.79(-0.14, 7.72)	0.059
Diastolic blood pressure (DBP)	82.6 (12.3)	83.9 (13.7)	0.274	82.4 (12.3)	81.1 (12.5)	0.106	2.32(-0.05, 4.69)	0.055
BMI	33.5 (7.8)	33.7 (8.2)	0.415	34.3 (8.6)	34.1 (8.2)	0.102	0.39(-0.05, 0.82)	0.082
Self-reported behaviors, M (SD)
Average number of days of physical activity, past 2 weeks	4.6 (5.1)	6.6 (5.8)	<0.001	5.7 (5.6)	5.9 (5.6)	0.840	1.90(0.58, 3.23)	0.005
General health
% reporting mental health status as “Excellent,” “Very good,” or “Good”	56.7	69.0	0.025	70.0	66.5	0.972	0.12(-0.10, 0.34)	0.303
Hypertension management
% reporting they are managing their hypertension well	80.5	88.8	0.019	85.1	86.7	0.781	0.07(-0.03, 0.17)	0.149
% with diagnosed hypertension at baseline who routinely measure their own blood pressure	45.6	60.7	0.001	44.3	43.8	0.897	0.15(0.03, 0.26)	0.013
Diabetes management
% reporting they are managing their diabetes well	65.7	80.0	0.011	75.0	84.5	0.073	0.05(-0.09, 0.18)	0.504
% with diagnosed diabetes at baseline who routinely measure their glycemic levels	74.0	72.1	0.662	63.2	59.2	0.561	0.02(-0.12, 0.16)	0.819
Asthma management
% reporting they are managing their asthma well	87.5	79.7	0.151	85.0	82.4	0.589	-0.05(-0.19, 0.09)	0.491

Note: Boldface indicates statistical significance (p<0.05). Absolute difference is shown for blood pressure, BMI, and average days of physical activity in the estimated between-group difference column. Difference in % improved is shown for percentage-based outcomes.

FU, follow-up.